Literature DB >> 25012663

Biased signaling favoring gi over β-arrestin promoted by an apelin fragment lacking the C-terminal phenylalanine.

Emilie Ceraudo1, Cécile Galanth1, Eric Carpentier2, Inmaculada Banegas-Font1, Anne-Marie Schonegge2, Rodrigo Alvear-Perez1, Xavier Iturrioz1, Michel Bouvier2, Catherine Llorens-Cortes3.   

Abstract

Apelin plays a prominent role in body fluid and cardiovascular homeostasis. We previously showed that the C-terminal Phe of apelin 17 (K17F) is crucial for triggering apelin receptor internalization and decreasing blood pressure (BP) but is not required for apelin binding or Gi protein coupling. Based on these findings, we hypothesized that the important role of the C-terminal Phe in BP decrease may be as a Gi-independent but β-arrestin-dependent signaling pathway that could involve MAPKs. For this purpose, we have used apelin fragments K17F and K16P (K17F with the C-terminal Phe deleted), which exhibit opposite profiles on apelin receptor internalization and BP. Using BRET-based biosensors, we showed that whereas K17F activates Gi and promotes β-arrestin recruitment to the receptor, K16P had a much reduced ability to promote β-arrestin recruitment while maintaining its Gi activating property, revealing the biased agonist character of K16P. We further show that both β-arrestin recruitment and apelin receptor internalization contribute to the K17F-stimulated ERK1/2 activity, whereas the K16P-promoted ERK1/2 activity is entirely Gi-dependent. In addition to providing new insights on the structural basis underlying the functional selectivity of apelin peptides, our study indicates that the β-arrestin-dependent ERK1/2 activation and not the Gi-dependent signaling may participate in K17F-induced BP decrease.
© 2014 by The American Society for Biochemistry and Molecular Biology, Inc.

Entities:  

Keywords:  Apelin; Apelin Receptor; Arrestin; Cell Signaling; Extracellular Signal-regulated Kinase (ERK); G Protein; G Protein-coupled Receptor (GPCR); Mitogen-activated Protein Kinase (MAPK); Pertussis Toxin

Mesh:

Substances:

Year:  2014        PMID: 25012663      PMCID: PMC4148883          DOI: 10.1074/jbc.M113.541698

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  65 in total

1.  Impaired heart contractility in Apelin gene-deficient mice associated with aging and pressure overload.

Authors:  Keiji Kuba; Liyong Zhang; Yumiko Imai; Sara Arab; Manyin Chen; Yuichiro Maekawa; Michael Leschnik; Andreas Leibbrandt; Mato Markovic; Mato Makovic; Julia Schwaighofer; Nadine Beetz; Renata Musialek; G Greg Neely; Vukoslav Komnenovic; Ursula Kolm; Bernhard Metzler; Romeo Ricci; Hiromitsu Hara; Arabella Meixner; Mai Nghiem; Xin Chen; Fayez Dawood; Kit Man Wong; Renu Sarao; Eva Cukerman; Akinori Kimura; Lutz Hein; Johann Thalhammer; Peter P Liu; Josef M Penninger
Journal:  Circ Res       Date:  2007-08-02       Impact factor: 17.367

Review 2.  Beta-arrestins and cell signaling.

Authors:  Scott M DeWire; Seungkirl Ahn; Robert J Lefkowitz; Sudha K Shenoy
Journal:  Annu Rev Physiol       Date:  2007       Impact factor: 19.318

3.  Reciprocal regulation of plasma apelin and vasopressin by osmotic stimuli.

Authors:  Michel Azizi; Xavier Iturrioz; Anne Blanchard; Séverine Peyrard; Nadia De Mota; Nicolas Chartrel; Hubert Vaudry; Pierre Corvol; Catherine Llorens-Cortes
Journal:  J Am Soc Nephrol       Date:  2008-02-13       Impact factor: 10.121

4.  Beta-arrestin2-mediated inotropic effects of the angiotensin II type 1A receptor in isolated cardiac myocytes.

Authors:  Keshava Rajagopal; Erin J Whalen; Jonathan D Violin; Jonathan A Stiber; Paul B Rosenberg; Richard T Premont; Thomas M Coffman; Howard A Rockman; Robert J Lefkowitz
Journal:  Proc Natl Acad Sci U S A       Date:  2006-10-23       Impact factor: 11.205

5.  The V2 vasopressin receptor stimulates ERK1/2 activity independently of heterotrimeric G protein signalling.

Authors:  Pascale G Charest; Geneviève Oligny-Longpré; Hélène Bonin; Mounia Azzi; Michel Bouvier
Journal:  Cell Signal       Date:  2006-06-03       Impact factor: 4.315

6.  M3 muscarinic acetylcholine receptor-mediated signaling is regulated by distinct mechanisms.

Authors:  Jiansong Luo; John M Busillo; Jeffrey L Benovic
Journal:  Mol Pharmacol       Date:  2008-04-03       Impact factor: 4.436

7.  Conformational rearrangements and signaling cascades involved in ligand-biased mitogen-activated protein kinase signaling through the beta1-adrenergic receptor.

Authors:  Ségolène Galandrin; Geneviève Oligny-Longpré; Hélène Bonin; Koji Ogawa; Céline Galés; Michel Bouvier
Journal:  Mol Pharmacol       Date:  2008-04-10       Impact factor: 4.436

8.  Mutations of beta-arrestin 2 that limit self-association also interfere with interactions with the beta2-adrenoceptor and the ERK1/2 MAPKs: implications for beta2-adrenoceptor signalling via the ERK1/2 MAPKs.

Authors:  Tian-Rui Xu; George S Baillie; Narinder Bhari; Thomas M Houslay; Andrew M Pitt; David R Adams; Walter Kolch; Miles D Houslay; Graeme Milligan
Journal:  Biochem J       Date:  2008-07-01       Impact factor: 3.857

9.  beta-arrestin-biased agonism at the beta2-adrenergic receptor.

Authors:  Matthew T Drake; Jonathan D Violin; Erin J Whalen; James W Wisler; Sudha K Shenoy; Robert J Lefkowitz
Journal:  J Biol Chem       Date:  2007-12-17       Impact factor: 5.157

10.  Structure and conformational changes in the C-terminal domain of the beta2-adrenoceptor: insights from fluorescence resonance energy transfer studies.

Authors:  Sébastien Granier; Samuel Kim; Aaron M Shafer; Venkata R P Ratnala; Juan José Fung; Richard N Zare; Brian Kobilka
Journal:  J Biol Chem       Date:  2007-03-08       Impact factor: 5.157

View more
  24 in total

1.  Human Neuropeptide S Receptor Is Activated via a Gαq Protein-biased Signaling Cascade by a Human Neuropeptide S Analog Lacking the C-terminal 10 Residues.

Authors:  Yuan Liao; Bin Lu; Qiang Ma; Gang Wu; Xiangru Lai; Jiashu Zang; Ying Shi; Dongxiang Liu; Feng Han; Naiming Zhou
Journal:  J Biol Chem       Date:  2016-02-10       Impact factor: 5.157

Review 2.  The apelinergic system: a perspective on challenges and opportunities in cardiovascular and metabolic disorders.

Authors:  Eric Marsault; Catherine Llorens-Cortes; Xavier Iturrioz; Hyung J Chun; Olivier Lesur; Gavin Y Oudit; Mannix Auger-Messier
Journal:  Ann N Y Acad Sci       Date:  2019-06-25       Impact factor: 5.691

3.  Protamine is an antagonist of apelin receptor, and its activity is reversed by heparin.

Authors:  Sophie Le Gonidec; Carline Chaves-Almagro; Yushi Bai; Hye Jin Kang; Allyson Smith; Estelle Wanecq; Xi-Ping Huang; Hervé Prats; Bernard Knibiehler; Bryan L Roth; Larry S Barak; Marc G Caron; Philippe Valet; Yves Audigier; Bernard Masri
Journal:  FASEB J       Date:  2017-02-27       Impact factor: 5.191

Review 4.  Advances in therapeutic peptides targeting G protein-coupled receptors.

Authors:  Anthony P Davenport; Conor C G Scully; Chris de Graaf; Alastair J H Brown; Janet J Maguire
Journal:  Nat Rev Drug Discov       Date:  2020-03-19       Impact factor: 84.694

Review 5.  Apelinergic System Structure and Function.

Authors:  Kyungsoo Shin; Calem Kenward; Jan K Rainey
Journal:  Compr Physiol       Date:  2017-12-12       Impact factor: 9.090

6.  Apelin-36 Modulates Blood Glucose and Body Weight Independently of Canonical APJ Receptor Signaling.

Authors:  Hadas Galon-Tilleman; Hong Yang; Maria A Bednarek; Sandra M Spurlock; Kevin J Paavola; Brian Ko; Carmen To; Jian Luo; Hui Tian; Lutz Jermutus; Joseph Grimsby; Cristina M Rondinone; Anish Konkar; Daniel D Kaplan
Journal:  J Biol Chem       Date:  2016-12-19       Impact factor: 5.157

7.  Bioactivity of the putative apelin proprotein expands the repertoire of apelin receptor ligands.

Authors:  Kyungsoo Shin; Nigel A Chapman; Muzaddid Sarker; Calem Kenward; Shuya K Huang; Nathan Weatherbee-Martin; Aditya Pandey; Denis J Dupré; Jan K Rainey
Journal:  Biochim Biophys Acta Gen Subj       Date:  2017-05-22       Impact factor: 3.770

8.  Pyrene-Apelin Conjugation Modulates Fluorophore- and Peptide-Micelle Interactions.

Authors:  Robin E Patterson; Nathan Weatherbee-Martin; Jan K Rainey
Journal:  J Phys Chem B       Date:  2017-04-26       Impact factor: 2.991

Review 9.  International Union of Basic and Clinical Pharmacology. CVII. Structure and Pharmacology of the Apelin Receptor with a Recommendation that Elabela/Toddler Is a Second Endogenous Peptide Ligand.

Authors:  Cai Read; Duuamene Nyimanu; Thomas L Williams; David J Huggins; Petra Sulentic; Robyn G C Macrae; Peiran Yang; Robert C Glen; Janet J Maguire; Anthony P Davenport
Journal:  Pharmacol Rev       Date:  2019-10       Impact factor: 25.468

Review 10.  Genetic and epigenetic control of ACE2 expression and its possible role in COVID-19.

Authors:  Rafael Silva Lima; Luiz Paulo Carvalho Rocha; Paula Rocha Moreira
Journal:  Cell Biochem Funct       Date:  2021-06-01       Impact factor: 3.963

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.